|Articles|March 11, 2021
- Pharmaceutical Executive-03-01-2021
- Volume 41
- Issue 3
Pharmaceutical Executive, March 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive March 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
The Amazon Effect: A Data-Fueled Customer Experienceover 5 years ago
Why ESG Performance Metrics Matterover 5 years ago
Pharma and Biotech’s 2020 Full-Year Viewover 5 years ago
Persevering for Patientsover 5 years ago
Biopharma’s Reputation Gets a Well-Earned Shot in the Armover 5 years ago
IP and Capitalover 5 years ago
IP and COVID-19over 5 years ago
Pharma Steps Up for Public Health Inequitiesover 5 years ago
FDA Relays Recent Achievements, Maps Plans for Progressover 5 years ago
IP and CollaborationAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory
3
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
4
Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D
5